BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28552233)

  • 1. Advanced imaging of transplant survival, fate, differentiation, and integration.
    Van Camp N; Diguet E; Hantraye P
    Prog Brain Res; 2017; 230():283-303. PubMed ID: 28552233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cell-derived neurons for transplantation in Huntington's disease.
    Li M; Rosser AE
    Prog Brain Res; 2017; 230():263-281. PubMed ID: 28552232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of three-dimensional substrate-adherent embryonic stem cell-derived neural aggregates for application in animal models of neurological disorders.
    Hargus G; Cui YF; Dihné M; Bernreuther C; Schachner M
    Curr Protoc Stem Cell Biol; 2012 May; Chapter 2():Unit 2D.11. PubMed ID: 22605646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stem cell therapy for neurodegenerative disorders].
    Meyer M; Jensen P; Rasmussen JZ
    Ugeskr Laeger; 2010 Sep; 172(38):2604-7. PubMed ID: 20920404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can human pluripotent stem cells help decipher and cure Huntington's disease?
    Perrier A; Peschanski M
    Cell Stem Cell; 2012 Aug; 11(2):153-61. PubMed ID: 22862942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.
    Drouin-Ouellet J
    Neurodegener Dis Manag; 2014; 4(4):297-307. PubMed ID: 25313986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
    Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
    Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells as promising therapeutic options for neurological disorders.
    Yoo J; Kim HS; Hwang DY
    J Cell Biochem; 2013 Apr; 114(4):743-53. PubMed ID: 23097262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease.
    Bosch M; Pineda JR; Suñol C; Petriz J; Cattaneo E; Alberch J; Canals JM
    Exp Neurol; 2004 Nov; 190(1):42-58. PubMed ID: 15473979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal cell transplantation for Parkinson's and Huntington's diseases.
    Dunnett SB; Kendall AL; Watts C; Torres EM
    Br Med Bull; 1997; 53(4):757-76. PubMed ID: 9536526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating cell therapies in animal models of Parkinson's and Huntington's disease: Current challenges and considerations.
    Lelos MJ
    Int Rev Neurobiol; 2022; 166():159-189. PubMed ID: 36424091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of neurodegenerative diseases.
    Phillips W; Michell A; Pruess H; Barker RA
    Methods Mol Biol; 2009; 549():137-55. PubMed ID: 19378201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rehabilitation training in neural restitution.
    Clinch S; Busse M; Döbrössy MD; Dunnett SB
    Prog Brain Res; 2017; 230():305-329. PubMed ID: 28552234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluripotent stem cells models for Huntington's disease: prospects and challenges.
    Carter RL; Chan AW
    J Genet Genomics; 2012 Jun; 39(6):253-9. PubMed ID: 22749012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging for optimization of stem cell therapy in Parkinson's disease.
    Hayashi T; Onoe H
    Expert Opin Biol Ther; 2013 Dec; 13(12):1631-8. PubMed ID: 24206114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.
    Grow DA; McCarrey JR; Navara CS
    Stem Cell Res; 2016 Sep; 17(2):352-366. PubMed ID: 27622596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.